Respiratory Device Hand-off To FDA Dental Group Intended To Achieve Parity
This article was originally published in The Gray Sheet
Executive Summary
Responsibility for reviewing respiratory device-related premarket submissions is expected to be transferred out of FDA's Division of Cardiovascular and Respiratory Devices (DCRD) to the Division of Dental, Infection Control and General Hospital Use Devices (DDIGD).
You may also be interested in...
ODE Division Director Ulatowski Appointed Office Of Compliance Chief
Center for Devices & Radiological Health veteran Timothy Ulatowski will assume the position of Office of Compliance director starting Jan. 22, pending final sign-off by FDA Commissioner Mark McClellan
ODE Division Director Ulatowski Appointed Office Of Compliance Chief
Center for Devices & Radiological Health veteran Timothy Ulatowski will assume the position of Office of Compliance director starting Jan. 22, pending final sign-off by FDA Commissioner Mark McClellan
FDA Considers Japan Scientific Exchange, Expansion of Canada Joint Reviews
A meeting between Japanese Ministry of Health and Welfare and Office of Device Evaluation officials tentatively scheduled for October will explore the possibility of a cooperative agreement for sharing premarket review expertise, FDA staffers report.